September 16, 2025 - 19:41

The Richmond Symphony has announced the appointment of Shantane Tho to the role of chief financial officer. In her new position, Tho will be responsible for managing the orchestra's financial operations, as well as overseeing human resources and administrative functions.
Prior to joining the Richmond Symphony, Tho held the position of chief financial administrative officer for the Virginia League of Conservation Voters. During her tenure there, she played a crucial role in leading finance, human resources, and development operations as a key member of the executive team.
With a strong background in financial management and a commitment to organizational excellence, Tho is expected to bring valuable expertise to the Richmond Symphony. Her appointment comes at a time when the orchestra is looking to enhance its operational efficiency and financial sustainability. The Richmond Symphony community is looking forward to her leadership as they continue to navigate the evolving landscape of the arts sector.
November 1, 2025 - 03:39
Strategies for Boosting Your Retirement Savings by 2025As the deadline for 2025 draws near, it`s crucial for investors to focus on maximizing their retirement savings. Financial experts suggest several strategies to enhance your portfolio as you...
October 31, 2025 - 06:07
Apple Surpasses Fourth Quarter Expectations, Stock Rises Despite Weak China SalesApple reported its fourth quarter earnings after the bell Thursday, revealing results that exceeded analysts` expectations. The tech giant`s performance was buoyed by strong sales in various...
October 30, 2025 - 00:16
The Fed's Rate Cut: Strategies to Optimize Your SavingsIn light of the recent Federal Reserve rate cut, individuals are reevaluating their savings strategies to ensure they maximize their returns. With interest rates fluctuating, the opportunity cost...
October 29, 2025 - 02:12
Beta Bionics Announces Strong Financial Performance for Q3 2025 and Upgraded Full Year GuidanceIRVINE, Calif., Oct. 28, 2025 -- Beta Bionics, Inc., a leader in diabetes management solutions, has reported impressive financial results for the third quarter of 2025, which ended on September 30....